What is Neogen's stock-based comp?

Neogen (NEOG) reported stock-based comp of $1.1M in Q4 2025.

How has Neogen's stock-based comp changed year-over-year?

Neogen's stock-based comp decreased by 73.8% year-over-year, from $4.2M to $1.1M.

What is the long-term trend for Neogen's stock-based comp?

Over 4 years (2021 to 2025), Neogen's stock-based comp has grown at a 28.0% compound annual growth rate (CAGR), from $6.44M to $17.29M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Neogen NEOG Stock-Based Comp

Stock-Based Comp at other companies

Thermo Fisher ScientificTMO

$83M+10.7%

Idexx LaboratoriesIDXX

$16.34M+11.8%

ZoetisZTS

$25M+47.1%

RevvityRVTY

$8.72M+12.7%

Agilent TechnologiesA

$32M+6.7%

NeoGenomicsNEO

$9.64M-10.4%

Other financials

Income statement

See full

Revenue$211.2M-4.4%

Gross profit$99.0M-10.2%

Operating income-$3.3M-161%

Net income-$17.0M-56.0%

EPS (diluted)-$0.08-60.0%

Balance sheet

See full

Cash & equivalents$159.9M+25.2%

Total debt$793.3M-11.2%

Total equity$2.1B-21.0%

Total assets$3.4B-16.8%

Cash flow

See full

Operating cash flow$22.7M+16.7%

CapEx$11.6M-64.7%

Free cash flow$11.1M+182%

Valuation

See full

Market cap$2B+93.1%

Enterprise value$2.63B+45.5%

P/S2.3×+1.1×

Profitability

See full

Gross margin45.2%-3.6pp

Operating margin-73.1%+77.7pp

Net margin-69.9%+30.8pp

FCF margin-14%—

Returns & leverage

See full

Return on equity-25.6%+28.8pp

Debt / equity0.4×0.0×

Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neogen's stock-based comp?: Neogen (NEOG) reported stock-based comp of $1.1M in Q4 2025.
How has Neogen's stock-based comp changed year-over-year?: Neogen's stock-based comp decreased by 73.8% year-over-year, from $4.2M to $1.1M.
What is the long-term trend for Neogen's stock-based comp?: Over 4 years (2021 to 2025), Neogen's stock-based comp has grown at a 28.0% compound annual growth rate (CAGR), from $6.44M to $17.29M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.